The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: thirtyfifth adult lung and heart-lung transplant report-2018; focus theme: multiorgan transplantation, J Heart Lung Transplant, vol.37, pp.1169-83, 2018. ,
Association of higher CD4(+) CD25(high) CD127(low), FoxP3(+), and IL-2(+) T cell frequencies early after lung transplantation with less chronic lung allograft dysfunction at two years, Am J Transplant, vol.17, pp.1637-1685, 2017. ,
Donor-specific and -nonspecific HLA antibodies and outcome post lung transplantation, Eur Respir J, vol.50, p.1701248, 2017. ,
Lung transplant outcomes: a review of survival, graft function, physiology, health-related quality of life and cost-effectiveness, Eur Respir J, vol.24, pp.674-85, 2004. ,
Technology and outcomes assessment in lung transplantation, Proc Am Thorac Soc, vol.6, pp.128-164, 2009. ,
Bronchiolitis obliterans syndrome-free survival after lung transplantation: an International Society for Heart and Lung Transplantation Thoracic Transplant Registry analysis, J Heart Lung Transplant, vol.38, pp.5-16, 2019. ,
, Biomarkers and surrogate endpoints: preferred definitions and conceptual framework, Biomarkers Definitions Working Group, vol.69, pp.89-95, 2001.
A new classification system for chronic lung allograft dysfunction, J Heart Lung Transplant, vol.33, pp.127-160, 2014. ,
Restrictive chronic lung allograft dysfunction: where are we now?, J Heart Lung Transplant, vol.34, pp.625-655, 2015. ,
Chronic lung allograft dysfunction: a systematic review of mechanisms, Transplantation, vol.100, pp.1803-1817, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-01831751
Parametric response mapping as an imaging biomarker in lung transplant recipients, Am J Respir Crit Care Med, vol.195, pp.942-52, 2017. ,
Restrictive allograft syndrome after lung transplantation: new radiological insights, Eur Radiol, vol.27, pp.2810-2817, 2017. ,
Association of methacholine challenge test with diagnosis of chronic lung allograft dysfunction in lung transplant patients, Clin Transplant, vol.32, 2018. ,
Does human leukocyte antigen matching influence the outcome of lung transplantation? An analysis of 3,549 lung transplantations, J Heart Lung Transplant, vol.19, pp.473-479, 2000. ,
Impact of HLA compatibility on lung transplant survival and evidence for an HLA restriction phenomenon: a collaborative transplant study report, Transplantation, vol.90, pp.912-919, 2010. ,
HLA mismatches influence lung transplant recipient survival, bronchiolitis obliterans and rejection: implications for donor lung allocation, J Heart Lung Transplant, vol.30, pp.426-460, 2011. ,
Influence of human leukocyte antigen mismatching on bronchiolitis obliterans syndrome in lung transplantation, J Heart Lung Transplant, vol.35, pp.186-94, 2016. ,
Impact of human leukocyte antigen mismatch on lung transplant outcome, Interact Cardiovasc Thorac Surg, vol.26, pp.859-64, 2018. ,
Relative impact of human leukocyte antigen mismatching and graft ischemic time after lung transplantation, 20. van den Berg JW, vol.27, pp.368-373, 2001. ,
The Munich-LTX-Score: predictor for survival after lung transplantation, Clin Transplant, vol.26, pp.173-83, 2012. ,
HLA matching at the eplet level protects against chronic lung allograft dysfunction, Am J Transplant, vol.16, pp.2695-703, 2016. ,
HLA-G * 01:04 approximately UTR3 Recipient correlates with lower survival and higher frequency of chronic rejection after lung transplantation, Am J Transplant, vol.15, pp.2413-2433, 2015. ,
HLA-E( * )01:03 Allele in Lung Transplant Recipients Correlates with Higher Chronic Lung Allograft Dysfunction Occurrence, J Immunol Res, p.1910852, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-01362578
Role of HLA-G as a predictive marker of low risk of chronic rejection in lung transplant recipients: a clinical prospective study, Am J Transplant, vol.15, pp.461-71, 2015. ,
Development of an antibody specific to major histocompatibility antigens detectable by flow cytometry after lung transplant is associated with bronchiolitis obliterans syndrome, Transplantation, vol.74, pp.799-804, 2002. ,
Pre-transplant panel reactive antibody in lung transplant recipients is associated with significantly worse post-transplant survival in a multicenter study, J Heart Lung Transplant, vol.24, pp.249-54, 2005. ,
Development of antibodies to human leukocyte antigen precedes development of antibodies to major histocompatibility class I-related chain A and are significantly associated with development of chronic rejection after human lung transplantation, Hum Immunol, vol.71, pp.560-565, 2010. ,
De novo donor-specific HLA antibodies are associated with early and high-grade bronchiolitis obliterans syndrome and death after lung transplantation, J Heart Lung Transplant, vol.33, pp.1288-94, 2014. ,
De-novo donor-specific anti-HLA antibodies 30 days after lung transplantation are associated with a worse outcome, J Heart Lung Transplant, vol.35, pp.1067-77, 2016. ,
Pretransplant panel reactive antibodies in human lung transplantation: an analysis of over 10,000 patients, Ann Thorac Surg, vol.85, pp.1919-1943, 2008. ,
Influence of panel-reactive antibodies on posttransplant outcomes in lung transplant recipients, Ann Thorac Surg, vol.69, pp.1520-1524, 2000. ,
Impact of pretransplant anti-HLA antibodies on outcomes in lung transplant candidates, Am J Respir Crit Care Med, vol.189, pp.1234-1243, 2014. ,
Prevalence of pre-transplant anti-HLA antibodies and their impact on outcomes in lung transplant recipients, BMC Pulm Med, vol.18, p.45, 2018. ,
The impact of pre-transplant allosensitization on outcomes after lung transplantation, J Heart Lung Transplant, vol.34, pp.1415-1437, 2015. ,
Survival in sensitized lung transplant recipients with perioperative desensitization, Am J Transplant, vol.15, pp.417-443, 2015. ,
Antibody desensitization therapy in highly sensitized lung transplant candidates, Am J Transplant, vol.14, pp.849-56, 2014. ,
Donor-specific antibodies are associated with antibody-mediated rejection, acute cellular rejection, bronchiolitis obliterans syndrome, and cystic fibrosis after lung transplantation, J Heart Lung Transplant, vol.32, pp.70-77, 2013. ,
Development of a multivariate prediction model for earlyonset bronchiolitis obliterans syndrome and restrictive allograft syndrome in lung transplantation, Front Med, vol.4, p.109, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-01608943
De novo DQ donor-specific antibodies are associated with chronic lung allograft dysfunction after lung transplantation, Am J Respir Crit Care Med, vol.194, pp.596-606, 2016. ,
Role of C1q-binding anti-HLA antibodies as a predictor of lung allograft outcome, Eur Respir J, vol.52, p.1701898, 2018. ,
Antibody-mediated rejection of the lung: a consensus report of the International Society for Heart and Lung Transplantation, J Heart Lung Transplant, vol.35, pp.397-406, 2016. ,
Evidence that humoral allograft rejection in lung transplant patients is not histocompatibility antigen-related, Am J Transplant, vol.3, pp.1264-72, 2003. ,
BAL neutrophilia in azithromycin-treated lung transplant recipients: clinical significance, Transpl Immunol, vol.33, pp.37-44, 2015. ,
Immunological diversity in phenotypes of chronic lung allograft dysfunction: a comprehensive immunohistochemical analysis, Transpl Int, vol.30, pp.134-177, 2017. ,
Antibodies to K-alpha 1 tubulin and collagen V are associated with chronic rejection after lung transplantation, Am J Transplant, vol.12, pp.2164-71, 2012. ,
Alloimmunity-induced autoimmunity as a potential mechanism in the pathogenesis of chronic rejection of human lung allografts ,
, J Heart Lung Transplant, vol.30, pp.624-655, 2011.
Emphysema associated autoreactive antibodies exacerbate post lung transplant ischemia reperfusion injury, Am J Respir Cell Mol Biol, vol.60, pp.678-86, 2018. ,
Prevalence of antibodies to lung self-antigens. (Kalpha1 tubulin and collagen V) and donor specific antibodies to HLA in lung transplant recipients and implications for lung transplant outcomes: single center experience, Transpl Immunol, vol.54, pp.65-72, 2019. ,
Pre-transplant antibodies to Kalpha1 tubulin and collagen-V in lung transplantation: clinical correlations, J Heart Lung Transplant, vol.32, pp.807-821, 2013. ,
Regulatory CD4+CD25+ T cells in the peripheral blood of lung transplant recipients: correlation with transplant outcome, Transplantation, vol.77, pp.762-768, 2004. ,
Analysis of long term CD4+CD25highCD127-T-reg cells kinetics in peripheral blood of lung transplant recipients, BMC Pulm Med, vol.17, p.102, 2017. ,
High circulating CD4(+)CD25(hi)FOXP3(+) T-cell subpopulation early after lung transplantation is associated with development of bronchiolitis obliterans syndrome, J Heart Lung Transplant, vol.37, pp.770-81, 2018. ,
, T regulatory cells in stable posttransplant bronchiolitis obliterans syndrome, vol.84, pp.908-924, 2007.
Decreased percentage of CD4+FoxP3+ cells in bronchoalveolar lavage from lung transplant recipients correlates with development of bronchiolitis obliterans syndrome, Transplantation, vol.90, pp.540-546, 2010. ,
Profiling of peripheral blood mononuclear cells does not accurately predict the bronchiolitis obliterans syndrome after lung transplantation, Transpl Immunol, vol.32, pp.195-200, 2015. ,
Humoral immunity in phenotypes of chronic lung allograft dysfunction: a broncho-alveolar lavage fluid analysis, Transpl Immunol, vol.38, pp.27-32, 2016. ,
The role of the IL23/IL17 axis in bronchiolitis obliterans syndrome after lung transplantation, Am J Transplant, vol.8, pp.1911-1931, 2008. ,
Prognostic value of bronchoalveolar lavage neutrophilia in stable lung transplant recipients, J Heart Lung Transplant, vol.28, pp.468-74, 2009. ,
Immune monitoring in renal transplantation: the search for biomarkers, Eur J Immunol, vol.46, pp.2695-704, 2016. ,
URL : https://hal.archives-ouvertes.fr/inserm-02150158
T regulatory cells play a significant role in modulating MHC class I antibody-induced obliterative airway disease ,
, Am J Transplant, vol.12, pp.2663-74, 2012.
Protection against bronchiolitis obliterans syndrome is associated with allograft CCR7+ CD45RA-T regulatory cells, PLoS ONE, vol.5, 2010. ,
The number of FoxP3+ cells in transbronchial lung allograft biopsies does not predict bronchiolitis obliterans syndrome within the first five years after transplantation, Clin Transplant, vol.29, pp.179-84, 2015. ,
Aspiration, localized pulmonary inflammation, and predictors of early-onset bronchiolitis obliterans syndrome after lung transplantation, J Am Coll Surg, vol.217, 2013. ,
The prognostic importance of CXCR3 chemokine during organizing pneumonia on the risk of chronic lung allograft dysfunction after lung transplantation, PLoS ONE, vol.12, p.180281, 2017. ,
Soluble CD59 is a novel biomarker for the prediction of obstructive chronic lung allograft dysfunction after lung transplantation, Sci Rep, vol.6, p.26274, 2016. ,
Rapid detection of donor cell free DNA in lung transplant recipients with rejections using donor-recipient HLA mismatch, Hum Immunol, vol.78, pp.342-351, 2017. ,
Late manifestation of alloantibody-associated injury and clinical pulmonary antibody-mediated rejection: evidence from cell-free DNA analysis, J Heart Lung Transplant, vol.37, pp.925-957, 2018. ,
Donor-derived exosomes with lung self-antigens in human lung allograft rejection, Am J Transplant, vol.17, pp.474-84, 2017. ,
Expression of miR-142-5p in peripheral blood mononuclear cells from renal transplant patients with chronic antibody-mediated rejection, PLoS ONE, vol.8, p.60702, 2013. ,
URL : https://hal.archives-ouvertes.fr/inserm-02165884
T cells promote bronchial epithelial cell secretion of matrix metalloproteinase-9 via a C-C chemokine receptor type 2 pathway: implications for chronic lung allograft dysfunction, Am J Transplant, vol.17, pp.1502-1516, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-01573742
YKL-40 and matrix metalloproteinases as potential biomarkers of inflammation and fibrosis in the development of bronchiolitis obliterans syndrome, Sarcoidosis Vasc Diffuse Lung Dis, vol.30, pp.28-35, 2013. ,
Activation of tissue remodeling precedes obliterative bronchiolitis in lung transplant recipients, Biomark Insights, vol.3, pp.351-360, 2008. ,
Pretransplant serum human chitinase-like glycoprotein YKL-40 concentrations independently predict bronchiolitis obliterans development in lung transplant recipients, J Thorac Cardiovasc Surg, vol.148, pp.273-81, 2014. ,
Blood gene expression predicts bronchiolitis obliterans syndrome. Front Immunol, vol.8, p.1841, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-01832982
Gene expression profiling of bronchoalveolar lavage cells preceding a clinical diagnosis of chronic lung allograft dysfunction, PLoS ONE, vol.12, 2017. ,
The common rejection module in chronic rejection post lung transplantation, PLoS ONE, vol.13, p.205107, 2018. ,
A common rejection module (CRM) for acute rejection across multiple organs identifies novel therapeutics for organ transplantation, J Exp Med, vol.210, pp.2205-2226, 2013. ,
Molecular profiling in lung biopsies of human pulmonary allografts to predict chronic lung allograft dysfunction, Am J Pathol, vol.185, pp.3178-88, 2015. ,
Serum miRNAs as potential biomarkers for the bronchiolitis obliterans syndrome after lung transplantation, Transpl Immunol, vol.42, pp.1-4, 2017. ,
Chronic effects of air pollution on lung function after lung transplantation in the Systems prediction of Chronic Lung Allograft Dysfunction (SysCLAD) study ,
URL : https://hal.archives-ouvertes.fr/hal-01521358
, Eur Respir J, vol.49, p.1600206, 2017.
Smoking resumption after lung transplantation: standardised screening and importance for long-term outcome, Eur Respir J, vol.43, pp.300-303, 2014. ,
Selfreported non-adherence to immunosuppressivemedication in adult lung transplant recipients-A single-center cross-sectional study, Clin Transplant, vol.32, 2018. ,